NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Piramal Life Sciences Limited (NSE: PIRLIFE)
PIRLIFE Technical Analysis
1
As on N/A PIRLIFE SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
PIRLIFESHARE Price
Open | N/A | Change | Price | % |
High | N/A | 1 Day | N/A | N/A |
Low | N/A | 1 Week | N/A | N/A |
Close | N/A | 1 Month | N/A | N/A |
Volume | N/A | 1 Year | N/A | N/A |
52 Week High N/A | 52 Week Low N/A |
NSE INDIA Most Active Stocks
IDEA | 6.72 | -8.82% |
YESBANK | 21.20 | -1.62% |
GTLINFRA | 1.53 | 2.68% |
EASEMYTRIP | 12.09 | 1.43% |
IRFC | 141.49 | 2.08% |
SUZLON | 61.53 | 0.74% |
RPOWER | 45.69 | 1.38% |
BEL | 363.75 | -0.04% |
UCOBANK | 32.19 | 3.91% |
SOUTHBANK | 28.77 | 4.43% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
PIRLIFE Daily Charts |
PIRLIFE Intraday Charts |
Whats New @ Bazaartrend |
PIRLIFE Free Analysis |
|
PIRLIFE Important Levels Intraday
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE |
PIRLIFE Target May 2025
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
PIRLIFE Weekly Target
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
PIRLIFE Target2025
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
Piramal Life Sciences Limited ( NSE INDIA Symbol : PIRLIFE )
Sector : Pharmaceuticals And Other Stocks in Same Sector
Sector : Pharmaceuticals And Other Stocks in Same Sector
PIRLIFE Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
PIRLIFE Other Details
Segment | BE | |
Market Capital | 0.00 | |
Sector | Pharmaceuticals | |
Industry | ||
Offical website | > echo $website ; ?> |
PIRLIFE Address
![]() |
N/A |
PIRLIFE Latest News
PIRLIFE Business Profile
Piramal Phytoca is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 60.23 crore.The company has reported a standalone sales of Rs 0.69 crore and a Net Loss of Rs 1.12 crore for the quarter ended Sep 2013.The company management includes Gautam Doshi - Director, Rajesh Laddha - Director, N L Bhatia - Director. It is listed on the BSE with a BSE Code of 532979 and the NSE with an NSE Code of PIRPHYTO.Its Registered office is at Piramal Tower, Ganpatrao Kadam Marg,,Lower Parel. Mumbai,Maharashtra - 400013.Their Registrars are Link Intime India Pvt. Ltd.
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service